A Hong Kong IPO will make one of the world’s richest biopharma families

13th June 2019 Uncategorised 0

China’s Hansoh Pharmaceutical is slated to go public in Hong Kong on Friday. The $1 billion raise puts it among the largest IPOs on the exchange this year. But perhaps what’s more interesting is how the market value will create one of the world’s wealthiest biopharma families.

More: A Hong Kong IPO will make one of the world’s richest biopharma families
Source: fierce